Avricore Health (AVCRF) Short-term Investments (2009 - 2026)

Avricore Health (AVCRF) has reported Short-term Investments for 14 consecutive years, with $7292.1 the latest figure, recorded in Q1 2026.

• In Q1 2026, Short-term Investments rose 4.63% year-over-year to $7292.1; the TTM figure through Mar 2026 stood at $7292.1 (up 4.63% YoY), while the FY2025 annual figure was $7157.2, down 2.01% from the prior year.
• Short-term Investments rose to $7292.1 in Q1 2026 per AVCRF's latest filing, from $7170.9 in the prior quarter.
• Across five years, Short-term Investments topped out at $244737.4 in Q1 2022 and bottomed at $6969.2 in Q1 2025.
• Historically, Short-term Investments has averaged $48694.3 across 5 years, with a median of $7366.3 in 2024.
• On a YoY basis, Short-term Investments climbed as much as 2997.55% in 2022 and fell as far as 97.0% in 2022.
• Avricore Health's Short-term Investments stood at $7367.0 in 2022, then fell by 0.29% to $7345.4 in 2023, then slipped by 2.54% to $7158.5 in 2024, then advanced by 0.17% to $7170.9 in 2025, then gained by 1.69% to $7292.1 in 2026.
• Business Quant data shows AVCRF's Short-term Investments at $7292.1 in Q1 2026, $7170.9 in Q4 2025, and $7266.4 in Q3 2025.